Supriya Lifescience LimitedNSE: SUPRIYA

Press Release Dec 09 2024

· Issued by Supriya Lifescience Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-09-2024-13

Supriya Lifescience Limited has informed the Exchange regarding a press release dated December 09, 2024, titled "Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing".

View Attachment

6ix hasn’t read this filing yet.

Supriya Lifescience Limited on 6ix

Earlier from Supriya Lifescience

Later from Supriya Lifescience

All Supriya Lifescience news releases